Becton Dickinson Reaches New 52-Week High (BDX)

NEW YORK ( TheStreet) -- Becton Dickinson (NYSE: BDX) hit a new 52-week high Thursday as it is currently trading at $102.75, above its previous 52-week high of $102.72 with 95,427 shares traded as of 10:36 a.m. ET. Average volume has been 948,600 shares over the past 30 days.

Becton Dickinson has a market cap of $19.79 billion and is part of the health care sector and health services industry. Shares are up 30.4% year to date as of the close of trading on Wednesday.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Becton Dickinson Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

What Happened to American Society Is Happening to the Stock Market, Too: Market Recon

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways